The Current Ratio as of December 2024 (TTM) for Immunocore Holdings plc (IMCR) is 3.78

According to Immunocore Holdings plc’s latest financial reports and current stock price. The company's current Current Ratio is 3.78. This represents a change of -19.25% compared to the average of 4.68 of the last 4 quarters.

Immunocore Holdings plc (IMCR) Historical Current Ratio (quarterly & annually)

How has IMCR Current Ratio performed in the past?

The mean historical Current Ratio of Immunocore Holdings plc over the last ten years is 3.42. The current 3.78 Current Ratio has changed 10.95% with respect to the historical average. Over the past ten years (40 quarters), IMCR's Current Ratio was at its highest in in the March 2021 quarter at 6.23. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Immunocore Holdings plc (IMCR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Immunocore Holdings plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Immunocore Holdings plc (IMCR) Average Current Ratio

How has IMCR Current Ratio performed in the past?

The current Current Ratio of Immunocore Holdings plc (IMCR) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Immunocore Holdings plc (IMCR) Current Ratio vs. Peers

How is IMCR’s Current Ratio compared to its peers?

Immunocore Holdings plc’s Current Ratio is less than Arcellx, Inc. (4.29), less than Ventyx Biosciences, Inc. (23.52), less than Vaxcyte, Inc. (17.88), less than DICE Therapeutics, Inc. (38.14), less than Nuvalent, Inc. (23.07), less than Viridian Therapeutics, Inc. (18.55), less than Gracell Biotechnologies Inc. (0), less than Theseus Pharmaceuticals, Inc. (7.73), less than Monte Rosa Therapeutics, Inc. (29.93), less than Design Therapeutics, Inc. (6.03), less than Erasca, Inc. (34.61), less than Mirum Pharmaceuticals, Inc. (11.00), greater than Larimar Therapeutics, Inc. (3.34), less than KalVista Pharmaceuticals, Inc. (13.10), less than Lyra Therapeutics, Inc. (6.87), greater than null (3.64),

Build a custom stock screener for Immunocore Holdings plc (IMCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunocore Holdings plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immunocore Holdings plc (IMCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immunocore Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.